Edward Hyde

1.2k citations

19 papers · 772 indexed · h-index 13

Impact in

Biotechnology top 10%
- Marine Sponges and Natural Products
Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
- Microbial Natural Products and Biosynthesis

Papers in ⓘ

Molecular Biology 5
- Receptor Mechanisms and Signaling 2
- Nicotinic Acetylcholine Receptors Study 2
Oncology 5
- Cancer Treatment and Pharmacology 2
- COVID-19 and healthcare impacts 2

Co-authors: John Q. Trojanowski (5 shared papers)Virginia M.‐Y. Lee (5 shared papers)Ronald J. Quinn (4 shared papers)Anthony R. Carroll (3 shared papers)Carlo Ballatore (4 shared papers)Wayne W. Carmichael (1 shared paper)Alex Crowe (2 shared papers)Moana Simpson (2 shared papers)
Journals: Journal of Medicinal Chemistry (4 papers)European Journal of Cardiovascular Nursing (2 papers)European Journal of Medicinal Chemistry (1 paper)Journal of the American Chemical Society (1 paper)Phytochemistry (1 paper)
Partner nations: United States Australia United Kingdom

In The Last Decade

Edward Hyde

17 papers receiving 753 citations

Peers

Countries citing papers authored by Edward Hyde

Since Specialization

Citations

This map shows the geographic impact of Edward Hyde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Hyde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Hyde more than expected).

Fields of papers citing papers by Edward Hyde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Hyde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Hyde. The network helps show where Edward Hyde may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward Hyde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Hyde Line = papers co-authored together Edward Hyde links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Structure and Function of the Third Intracellular Loop of the 5‐Hydroxytryptamine_2A Receptor: The Third Intracellular Loop Is α‐Helical and Binds Purified Arrestins Journal of Neurochemistry ·Edward I. Gelber, Wesley K. Kroeze, Bryan L. Roth, J.A. Gray, Christine A. Sinar, Edward Hyde, Vsevolod V. Gurevich, Jeffrey Benovic, Bryan L. Roth	1999	88
2	High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation Biochemical and Biophysical Research Communications ·Alex Crowe, Carlo Ballatore, Edward Hyde, John Q. Trojanowski, Virginia M.‐Y. Lee	2007	87
3	Actinophyllic Acid, a Potent Indole Alkaloid Inhibitor of the Coupled Enzyme Assay Carboxypeptidase U/Hippuricase from the Leaves of Alstonia actinophylla (Apocynaceae) The Journal of Organic Chemistry ·Anthony R. Carroll, Edward Hyde, Jill Smith, Ronald J. Quinn, Gordon P. Guymer, Paul I. Forster	2005	87
4	Dysinosin A: A Novel Inhibitor of Factor VIIa and Thrombin from a New Genus and Species of Australian Sponge of the Family Dysideidae Journal of the American Chemical Society ·Anthony R. Carroll, Gregory K. Pierens, Greg Fechner, Priscila de Almeida Leone, Anna Ngo, Moana Simpson, Edward Hyde, John N. A. Hooper, Stig-Lennart Boström, Djordje Müsil, Ronald J. Quinn	2002	85
5	Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies Journal of Medicinal Chemistry ·Kevin Lou, Yuemang Yao, Adam T. Hoye, Michael J. James, Anne‐Sophie Cornec, Edward Hyde, Bryant Gay, Virginia M.‐Y. Lee, John Q. Trojanowski, Amos B. Smith, Kurt R. Brunden, Carlo Ballatore	2014	73
6	Acupressure therapy for morning sickness A controlled clinical trial Journal of Nurse-Midwifery ·Edward Hyde	1989	58
7	Dysinosins B−D, Inhibitors of Factor VIIa and Thrombin from the Australian SpongeLamellodysideachlorea Journal of Natural Products ·Anthony R. Carroll, Malcolm S. Buchanan, Annette Edser, Edward Hyde, Moana Simpson, Ronald J. Quinn	2004	58
8	Calcium-sensing soluble adenylyl cyclase mediates TNF signal transduction in human neutrophils The Journal of Experimental Medicine ·Hyunsil Han, A. Stessin, Julia Roberts, Kenneth C. Hess, Narinder Gautam, Margarita Kamenetsky, Olivia Lou, Edward Hyde, Noah Nathan, William A. Müller, Jochen Buck, Lonny R. Levin, Carl Nathan	2005	54
9	Anatoxin‐A(S), a naturally occurring organophosphate, is an irreversible active site‐directed inhibitor of acetylcholinesterase (EC 3.1.1.7) Journal of Biochemical Toxicology ·Edward Hyde, Wayne W. Carmichael	1991	49
10	Discovery of Brain-Penetrant, Orally Bioavailable Aminothienopyridazine Inhibitors of Tau Aggregation Journal of Medicinal Chemistry ·Carlo Ballatore, Kurt R. Brunden, Francesco Piscitelli, Michael J. James, Alex Crowe, Yuemang Yao, Edward Hyde, John Q. Trojanowski, Virginia M.‐Y. Lee, Amos B. Smith	2010	39
11	Sensitive Fluorescence Polarization Technique for Rapid Screening of α-Synuclein Oligomerization/Fibrillization Inhibitors Biochemistry ·Kelvin C. Luk, Edward Hyde, John Q. Trojanowski, Virginia M.‐Y. Lee	2007	36
12	Engineering a region of bulk tolerance in the 5-HT2A receptor European Journal of Medicinal Chemistry ·Richard B. Westkaemper, Edward Hyde, M S Choudhary, Naseem Khan, Edward I Gelbar, Richard A. Glennon, Bryan L. Roth	1999	18
13	Paclitaxel C-10 carbamates: Potential candidates for the treatment of neurodegenerative tauopathies Bioorganic & Medicinal Chemistry Letters ·Carlo Ballatore, Edward Hyde, Robert F. Deiches, Virginia M.‐Y. Lee, John Q. Trojanowski, Donna M. Huryn, Amos B. Smith	2007	16
14	Evidence for a Carbocation Intermediate during Conversion of Bipinnatin-A and -C into Irreversible Inhibitors of Nicotinic Acetylcholine Receptors Journal of Medicinal Chemistry ·Edward Hyde, Stacy M. Thornhill, A Boyer, Stewart N. Abramson	1995	8
15	Irreversible Inhibitors of Nicotinic Acetylcholine Receptors: Isolation and Structural Characterization of the Biologically Active Solvolysis Products of Bipinnatin-A and Bipinnatin-C Journal of Medicinal Chemistry ·Edward Hyde, A Boyer, Pei Tang, Yan Xu, Stewart N. Abramson	1995	8
16	Cardenolide Glycosides from Elaeodendron australe var. integrifolium Phytochemistry ·Mark S. Butler, Leanne Towerzey, Ngoc Bich Pham, Edward Hyde, Sao Khemar Wadi, Gordon P. Guymer, Ronald J. Quinn	2013	6
17	The impact of the COVID-19 pandemic on recovery from cardiac surgery: 1-year outcomes European Journal of Cardiovascular Nursing ·Julie Sanders, Teofila Bueser, Emma Beaumont, Matthew Dodd, Sarah E Murray, Gareth Owens, Alan Berry, Edward Hyde, Tim Clayton, Aung Oo	2022	1
18	Telecommunications and Technology Communication Booknotes ·Charles J. Sippl, Charles P. Sippl, Walter S. Baer, Leland L. Johnson, Edward W. Merros, Lester G. Lindley, Nick Lyons, Charles F. Phillips, Calvin A. Kent, Richard Oppedahl, Lynn Stephens, Edward Hyde, Peter Shapiro, Arlene Karlin, Gordon Emrie	1976	1
19	The impact of the COVID-19 pandemic on recovery from cardiac surgery over time: results of the CardiacCovid study from three UK national lockdowns European Journal of Cardiovascular Nursing ·Julie Sanders, Emma Beaumont, Matthew Dodd, Sarah E Murray, Gareth Owens, Alan Berry, Edward Hyde, Teofila Bueser, Tim Clayton, Aung Oo	2023	0

About Edward Hyde

Edward Hyde is a scholar working on Molecular Biology, Oncology, Physiology, Organic Chemistry and Cancer Research, having authored 19 papers that have together received 772 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Cancer Treatment and Pharmacology (2 papers), Receptor Mechanisms and Signaling (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Cardiac Health and Mental Health (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers), COVID-19 and healthcare impacts (2 papers) and Marine Sponges and Natural Products (2 papers). The work is most often cited by research in Biotechnology (87 citations), Pharmacology (157 citations), Organic Chemistry (226 citations), Cellular and Molecular Neuroscience (143 citations) and Physiology (179 citations). Edward Hyde has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include John Q. Trojanowski, Virginia M.‐Y. Lee, Ronald J. Quinn, Anthony R. Carroll, Carlo Ballatore, Wayne W. Carmichael, Alex Crowe, Moana Simpson, Paul I. Forster and Gordon P. Guymer. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Cardiovascular Nursing, European Journal of Medicinal Chemistry, Journal of the American Chemical Society and Phytochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact